Moore Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,000
Closed -$2.7M 592
2024
Q2
$2.7M Buy
+100,000
New +$2.08M 0.05% 250
2021
Q3
Sell
-15,000
Closed -$718K 907
2021
Q2
$718K Hold
15,000
0.01% 551
2021
Q1
$760K Sell
15,000
-10,000
-40% -$556K 0.01% 526
2020
Q4
$1.57M Hold
25,000
0.02% 376
2020
Q3
$1.68M Hold
25,000
0.03% 272
2020
Q2
$1.05M Buy
+25,000
New +$960K 0.03% 207

Other funds holding SILK

Moore Capital Management's SILK Position: Q3 2024 in Review

Moore Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 100,000 shares — an estimated $2.7M sold.

Moore Capital Management first reported a position in SILK in Q2 2020 and held it in 6 quarters. The position peaked at $2.7M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Moore Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Moore Capital Management sold 100,000 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $2.7M.
  • Moore Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Moore Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $2.7M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Moore Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.